CompletedNCT00280293
Lamotrigine or placebo for cocaine cravings and depression in bipolarity
About this title
Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
Read the official source — NCT00280293Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateMarch 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 112
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00280293
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine and Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
